XENE
Xenon Pharmaceuticals Inc.
$67.71
+0.41 (+0.61%)
At close · Jul 15
Market Cap
$6.47B
Shares
96,665,550
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-02-27 | $400,000,000 | — | 2026-02-26 | — | 10-Q , filed 2026-05-07 |
Key facts
CIK
1582313
CUSIP
98420N105
13F (30d)
12 filings
12 filers
Visit website
Investor relations